Radiomics for severe asthma phenotyping and endotyping
N. Zounemat Kermani (London, United Kingdom), G. Macis (Roma, Italy), P. Bakke (Bergen, Norway), M. Caruso (Catania, Italy), P. Chanez (Masrseille, France), R. Djukanovic (Southampton, United Kingdom), S. Fowler (Manchester, United Kingdom), Y. Guo (London, United Kingdom), I. Horvath (Budapest, Hungary), P. Howarth (Southampton, United Kingdom), A. Maitland-Van Der Zee (Amsterdam, Netherlands), M. Malerba (Novara, Italy), G. Roberts (Southampton, United Kingdom), M. Sanak (Krakow, Poland), D. Shaw (Nottingham, United Kingdom), S. Wilson (Southampton, United Kingdom), S. Siddiqui (London, United Kingdom), S. Dahlen (Stockholm, Sweden), K. Chung (London, United Kingdom), I. Adcock (London, United Kingdom), P. Montuschi (Roma, Italy), ,. On Behalf Of The U-Biopred Study Group (Roma, Italy)
Source: International Congress 2022 – Chronic airway diseases: from phenotypes to severity
Session: Chronic airway diseases: from phenotypes to severity
Session type: Oral Presentation
Number: 1411
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Zounemat Kermani (London, United Kingdom), G. Macis (Roma, Italy), P. Bakke (Bergen, Norway), M. Caruso (Catania, Italy), P. Chanez (Masrseille, France), R. Djukanovic (Southampton, United Kingdom), S. Fowler (Manchester, United Kingdom), Y. Guo (London, United Kingdom), I. Horvath (Budapest, Hungary), P. Howarth (Southampton, United Kingdom), A. Maitland-Van Der Zee (Amsterdam, Netherlands), M. Malerba (Novara, Italy), G. Roberts (Southampton, United Kingdom), M. Sanak (Krakow, Poland), D. Shaw (Nottingham, United Kingdom), S. Wilson (Southampton, United Kingdom), S. Siddiqui (London, United Kingdom), S. Dahlen (Stockholm, Sweden), K. Chung (London, United Kingdom), I. Adcock (London, United Kingdom), P. Montuschi (Roma, Italy), ,. On Behalf Of The U-Biopred Study Group (Roma, Italy). Radiomics for severe asthma phenotyping and endotyping. 1411
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|